Free Trial

Lunai Bioworks (RENB) Institutional Ownership

Lunai Bioworks logo
$0.13 -0.01 (-6.12%)
As of 12:31 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Institutional Ownership Changes (13F Filings) for Lunai Bioworks (NASDAQ:RENB)

Current
Institutional Ownership
Percentage
71.41%
Number of
Institutional Buyers
(last 12 months)
24
Total
Institutional Inflows
(last 12 months)
$2.74M
Number of
Institutional Sellers
(last 12 months)
3
Total
Institutional Outflows
(last 12 months)
$675.96K
Get RENB Insider Trade Alerts

Want to know when executives and insiders are buying or selling Lunai Bioworks stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

RENB Institutional Buying and Selling by Quarter

Lunai Bioworks Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/14/2025 Jane Street Group LLC893,046$258K0.0%N/A0.519%
8/14/2025 Qube Research & Technologies Ltd228,885$66K0.0%N/A0.133%
8/13/2025 Marshall Wace LLP309,350$90K0.0%N/A0.180%
8/8/2025 Geode Capital Management LLC1,015,917$294K0.0%-57.1%0.590%
6/27/2025 Goldman Sachs Group Inc.182,054$99K0.0%-50.1%0.106%
5/16/2025Goldman Sachs Group Inc.182,054$99K0.0%-50.1%0.115%
5/12/2025Nuveen LLC151,681$82K0.0%N/A0.096%
2/17/2025ProShare Advisors LLC32,570$27K0.0%N/A0.021%
2/17/2025Nuveen Asset Management LLC151,681$127K0.0%+128.8%0.096%
2/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.64,923$54K0.0%+174.8%0.041%
2/17/2025Deutsche Bank AG127,437$107K0.0%N/A0.080%
2/17/2025Cantor Fitzgerald L. P.300,000$251K0.0%+200.0%0.189%
2/14/2025Northern Trust Corp889,357$743K0.0%+49.5%0.560%
2/14/2025The Manufacturers Life Insurance Company45,797$38K0.0%N/A0.029%
2/14/2025Voya Investment Management LLC35,312$30K0.0%N/A0.022%
2/14/2025Price T Rowe Associates Inc. MD45,198$38K0.0%+183.5%0.028%
2/14/2025MetLife Investment Management LLC75,454$63K0.0%N/A0.048%
2/13/2025Barclays PLC179,844$150K0.0%+158.7%0.113%
2/13/2025Wells Fargo & Company MN59,101$49K0.0%+224.9%0.037%
2/12/2025Geode Capital Management LLC2,332,634$1.95M0.0%+48.4%1.470%
2/12/2025JPMorgan Chase & Co.353,833$296K0.0%+280.4%0.223%
2/11/2025Corebridge Financial Inc.57,495$48K0.0%+114.8%0.036%
2/6/2025Charles Schwab Investment Management Inc.362,126$303K0.0%+82.0%0.228%
2/4/2025Bank of New York Mellon Corp223,915$187K0.0%+137.2%0.141%
1/31/2025New York State Common Retirement Fund52,500$44K0.0%-21.3%0.033%
1/30/2025Rhumbline Advisers112,960$94K0.0%+122.6%0.071%
1/17/2025SG Americas Securities LLC51,725$43K0.0%+193.3%0.033%
12/26/2024JPMorgan Chase & Co.93,010$45K0.0%+347.6%0.059%
11/19/2024Barclays PLC69,531$34K0.0%+315.7%0.044%
11/16/2024Geode Capital Management LLC1,572,290$760K0.0%-9.0%0.972%
11/15/2024Barclays PLC69,531$34K0.0%+315.7%0.043%
11/15/2024State Street Corp1,323,832$640K0.0%+3.8%0.819%
8/1/2024Rhumbline Advisers45,197$79K0.0%N/A0.031%
7/26/2024Bank of New York Mellon Corp125,461$220K0.0%N/A0.085%
5/17/2024Tidal Investments LLC36,972$98K0.0%N/A0.026%
5/10/2024Vanguard Group Inc.3,916,672$10.38M0.0%+904.0%2.726%
5/7/2024SG Americas Securities LLC17,263$46K0.0%N/A0.012%
(Data available from 1/1/2016 forward)

RENB Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of RENB shares?

During the previous two years, 28 institutional investors and hedge funds held shares of Lunai Bioworks. The most heavily invested institutionals were Vanguard Group Inc. ($10.38M), Northern Trust Corp ($743K), State Street Corp ($640K), Charles Schwab Investment Management Inc. ($303K), JPMorgan Chase & Co. ($296K), Geode Capital Management LLC ($294K), and Jane Street Group LLC ($258K).Learn more on Lunai Bioworks' institutional investors.

What percentage of Lunai Bioworks' stock is owned by institutional investors?

71.41% of Lunai Bioworks' stock is owned by institutional investors. Learn more on RENB's institutional investor holdings.

Which institutional investors have been buying Lunai Bioworks' stock?

Of the 26 institutional investors that purchased Lunai Bioworks' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Vanguard Group Inc. ($3.53M), Jane Street Group LLC ($893.05K), Geode Capital Management LLC ($760.34K), JPMorgan Chase & Co. ($333.05K), Marshall Wace LLP ($309.35K), Northern Trust Corp ($294.47K), and Bank of New York Mellon Corp ($254.99K).

How much institutional buying is happening at Lunai Bioworks?

Institutional investors have bought a total of 4,367,996 shares in the last 24 months. This purchase volume represents approximately $2.74M in transactions.

Which of Lunai Bioworks' major shareholders have been selling company stock?

The following institutional investors have sold Lunai Bioworks stock in the last 24 months: Geode Capital Management LLC ($1.51M), Goldman Sachs Group Inc. ($364.85K), and New York State Common Retirement Fund ($14.20K).

How much institutional selling is happening at Lunai Bioworks?

Institutional investors have sold a total of 1,886,786 shares in the last 24 months. This volume of shares sold represents approximately $675.96K in transactions.



This page (NASDAQ:RENB) was last updated on 9/26/2025 by MarketBeat.com Staff
From Our Partners